More Details on This News

Biocon Limited conducted its Extra-Ordinary General Meeting (EGM) on Wednesday, December 31, 2025, via Video Conferencing (VC) / Other Audio Visual Means (OAVM). The meeting, which commenced at 2:30 PM IST, addressed several key business items as outlined in the EGM Notice dated December 06, 2025.

The EGM was attended by 63 Members, along with Directors and Key Managerial Personnel, including Executive Chairperson Ms. Kiran Mazumdar-Shaw and MD & CEO Mr. Siddharth Mittal. The proceedings were conducted in compliance with relevant Ministry of Corporate Affairs (MCA) circulars and SEBI Listing Regulations.

Six resolutions were presented for member approval. These included proposals for increasing the authorized share capital, amending the Memorandum of Association, increasing limits for investments and loans under Section 186 of the Companies Act, 2013, issuing equity shares on a preferential basis for consideration other than cash, raising funds through equity issuance, granting special rights to investors, and approving material related party transactions with Mylan Inc.

Remote e-voting was available from December 26, 2025, to December 30, 2025. Members who had not voted remotely could participate via e-voting during the EGM. The combined results of remote and in-meeting e-voting, along with the scrutinizer's report, will be intimated to the stock exchanges within two working days and made available on the company's website.

The meeting concluded at 3:29 PM IST after discussions and clarifications on all resolutions. The proceedings of the EGM have been enclosed and made available on the company's website.